Biogen Presents Data from Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab at 2016 Clinical Trials on Alzheimer’s Disease Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. SPY
4. ABBV
5. META
6. ACN
7. BLZE
8. IBM
9. NKE
10. MU

Go back to Biogen Presents Data from Phase 1b Study of Investigational Alzheimer’s Disease Treatment Aducanumab at 2016 Clinical Trials on Alzheimer’s Disease Meeting
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 197.19 --0 (-0%)
Previous Close $197.19    52 Week High $333.65 
Open $197.19    52 Week Low $223.02 
Day High $197.19    P/E 25.25 
Day Low $197.19    EPS $7.81 
Volume 133